Bond & Devick Financial Network’s iShares Biotechnology ETF IBB Stock Holding History

Bond & Devick Financial Network’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$305K	Buy	1,604 +201	+14%	+$34.5K	0.08%	152
2026 Q1	$237K	Hold	1,403	–	–	0.07%	173
2025 Q4	$237K	Hold	1,403	–	–	0.07%	165
2025 Q3	$203K	Buy	+1,403	New	+$192K	0.06%	185
2025 Q1	–	Sell	-1,403	Closed	-$204K	–	164
2024 Q4	$204K	Hold	1,403	–	–	0.09%	154
2024 Q3	$204K	Sell	1,403 -142	-9%	-$20.5K	0.09%	154
2024 Q2	$212K	Hold	1,545	–	–	0.11%	139
2024 Q1	$212K	Hold	1,545	–	–	0.12%	139
2023 Q4	$210K	Buy	+1,545	New	+$189K	0.12%	139
2022 Q1	–	Sell	-1,487	Closed	-$227K	–	111
2021 Q4	$227K	Buy	+1,487	New	+$230K	0.17%	104
2021 Q3	–	Sell	-1,227	Closed	-$201K	–	108
2021 Q2	$201K	Buy	+1,227	New	+$189K	0.17%	105

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Bond & Devick Financial Network's IBB Position: Q2 2026 in Review

Bond & Devick Financial Network increased its iShares Biotechnology ETF (IBB) stake by 14% in Q2 2026, buying an estimated $34.5K and bringing the position to 1,604 shares worth $305K. The position accounts for 0.08% of the portfolio, ranked #152.

Bond & Devick Financial Network first reported a position in IBB in Q2 2021 and has held it in 11 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Bond & Devick Financial Network held 1,604 shares of iShares Biotechnology ETF worth $305K as of Q2 2026.
Bond & Devick Financial Network bought 201 iShares Biotechnology ETF shares in Q2 2026, an estimated $34.5K.
iShares Biotechnology ETF made up 0.08% of Bond & Devick Financial Network's portfolio in Q2 2026, its #152 holding.
Bond & Devick Financial Network first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 11 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Bond & Devick Financial Network's 13F filing for Q2 2026, filed 16 Jul 2026.